Evolutionary Genomics Inc Common Stock (CE) (FNAM)
USOTC
Year End December 30 2022 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 33k | 115k | 123k | 13k | 0 | 0 |
Operating Income | -1.3M | -837k | -775k | -2.88M | -2.88M | -2.01M |
Pre Tax Income | -1.07M | -1.1M | -761k | -2.7M | -2.79M | -1.94M |
Net Income | -782k | -1.34M | -1.06M | -2M | -3.08M | -2.25M |
Preferred Dividends | -242k | -242k | -270k | -285k | -285k | -313k |
Basic Earnings Per Share (EPS) | -0.133 | -0.228 | -0.181 | -0.34 | -0.418 | -0.273 |
EBIT | -1.3M | -837k | -775k | -2.81M | -2.8M | -1.94M |
EBITDA | -1.26M | -796k | -734k | -2.47M | -1.84M | -992k |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.